For people with prediabetes who are overweight or obese, adding 3.0 mg of liraglutide for three years to a diet and exercise plan may lead to major health improvements, new industry-sponsored research suggests. The results ...
Apr 4, 2016
0
0
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that higher levels of testosterone were associated with reduced loss of lean muscle mass in older ...
Oct 27, 2011
0
0
A new study shows that although gastric bypass surgery reverses Type 2 diabetes in a large percentage of obese patients, the disease recurs in about 21 percent of them within three to five years. The study results will be ...
Jun 25, 2012
0
0
Exposure to cold temperatures can convert white fat tissue from the thighs and belly to beige fat that burns calories for heat, but this biological response is hampered in obese people, according to a new study published ...
Oct 9, 2014
0
1
A news study finds that the worse a woman's skin wrinkles are during the first few years of menopause, the lower her bone density is.
Jun 5, 2011
0
1
Combining a temporary one-year intestinal bypass device with the drug liraglutide helps patients lose weight and improve their diabetes control better than using either the device or the drug alone, new research from the ...
Apr 3, 2016
0
11
Obstructive sleep apnea (OSA) is prevalent in obese, pregnant Asian women with gestational diabetes, even when their diabetes is controlled by diet, a new study from Thailand finds. Study results, which also connect the severity ...
Mar 7, 2015
0
18
Vitamin D-deficient individuals are twice as likely to be diagnosed with schizophrenia as people who have sufficient levels of the vitamin, according to a new study published in the Endocrine Society's Journal of Clinical ...
Jul 22, 2014
0
0
An unborn child's gender can affect the mother's risk of developing gestational diabetes or Type 2 diabetes later in life, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & ...
May 20, 2015
0
170
Fezolinetant significantly reduced the frequency and severity of moderate-to-severe vasomotor symptoms (VMS), or hot flashes, associated with menopause, according to a Phase 3 industry-sponsored study being presented Saturday ...
Jun 11, 2022
0
17
